MIST — Milestone Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- $81.50m
- $49.78m
- $1.00m
- 18
- 13
- 30
- 10
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 120 | 142 | 114 | 64.6 | 66 |
Net Total Receivables | 0.836 | 0.948 | 0.483 | 1.21 | 3.85 |
Prepaid Expenses | |||||
Total Current Assets | 122 | 149 | 119 | 71.8 | 73 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.929 | 1.29 | 0.926 | 2.68 | 2.19 |
Total Assets | 123 | 150 | 120 | 74.5 | 75.2 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8.33 | 6.16 | 6.78 | 6.14 | 7.23 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 8.51 | 6.86 | 7.25 | 8.13 | 58.5 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 115 | 143 | 113 | 66.3 | 16.8 |
Total Liabilities & Shareholders' Equity | 123 | 150 | 120 | 74.5 | 75.2 |
Total Common Shares Outstanding |